abstract: Ovaries surgically removed for fertility preservation from a total of 24 women served as a source of human small antral follicles, including the follicular fluid (FF) and the corresponding granulosa cells (GC). The FF was used to evaluate the intrafollicular concentrations of anti-Müllerian hormone (AMH), inhibin-B, estradiol, progesterone, androstenedione and testosterone. In GC mRNA expression of the AMH type II receptor (AMH-r2) was determined and correlated to the mRNA expression of CYP19 (aromatase), FSH-receptor (FSHr) and LH-receptor (LH-r) and to the hormonal profiles of the corresponding FF. GC and FF from a total of 64 follicles (diameter of 3-9 mm) were evaluated. Concentrations of AMH in FF showed a highly significant inverse correlation with CYP19 mRNA expression in the corresponding GC and with concentrations of estradiol, progesterone and inhibin-B in the FF. However, a small subgroup of follicles exhibited high levels of AMH simultaneously with relative high levels of CYP19 mRNA. In contrast to AMH, mRNA expression of AMH-r2 was significantly positively correlated to the mRNA expression of FSH-r and CYP 19, but failed to correlate to any other measured parameters. These data confirms an intimate correlation between follicular AMH levels, AMH-r2, FSH-r expression and estradiol secretion in the developing human follicle.
Introduction
Anti-Müllerian hormone (AMH) is a member of the TGF-b family of growth factors and its only site of expression in the female is the granulosa cell of the developing follicle (Matzuk et al., 2002; Donahoe et al., 2003; Knight and Glister, 2006) . The expression of AMH is drastically reduced once the follicle has reached a diameter of around 8-10 mm in humans coinciding with the stage at which follicular selection normally takes place during the natural menstrual cycle (Weenen et al., 2004; Visser et al., 2006) . The concentration of AMH in fluid from small human antral follicles has recently been shown to be very high compared with circulation, reaching levels of several hundred ng/ml when compared with just a few ng/ml in circulation (Yding Andersen and Byskov, 2006; . Furthermore concentrations of AMH in the fluid from such small follicles exceed the concentration of inhibin-B, another import member of the TGF-b family of growth factors, with approximately one order of magnitude, suggesting that AMH alongside inhibin-B plays an important function in follicular development (Yding Andersen and Byskov, 2006; . Despite this pronounced expression pattern of AMH and its presence in high concentrations, the precise function of AMH in follicular development has not yet been determined. Based mainly on studies in rodents the current dogma suggests that AMH acts to inhibit FSH function on the follicle and thereby limits follicular recruitment (Durlinger et al., 2001 (Durlinger et al., , 2002 .
However, a number of studies have suggested that AMH also may interfere with ovarian steroidogenesis (Kim et al., 1992; Seifer et al., 1993) . Further, in fluid from small human antral follicles a very robust negative correlation was found between the concentration of AMH and estradiol, in contrast to that of intrafollicular testosterone concentrations that did not correlate to AMH levels (Yding Andersen and Byskov, 2006; . These results corroborate studies performed more than 20 years ago in which it was found that AMH had a strong negative effect on the secretion of estradiol by fetal sheep ovaries in vitro (Vigier et al., 1989) . This study showed that AMH inhibited estradiol secretion in the fetal sheep ovary by reducing expression of the aromatase enzyme (CYP19), the essential enzyme converting androgen to estrogen. Enhancement of the aromatase activity by increasing levels of cAMP in the culture medium was also inhibited by AMH (Vigier et al., 1989) . Recently, a study showed that AMH added to the culture medium of human granulosa-lutein cells from patients undergoing assisted reproduction attenuated the FSH induced estradiol secretion by causing a reduction in the aromatase expression documented by a decreased expression at both the gene and the protein level (Grossman et al., 2008) . In addition, studies in bovine granulosa cells (GC) from antral follicles also found an inverse correlation between FF AMH on one side and FF estradiol levels and aromatase expression on the other side (Monniaux et al., 2008; Rico et al., 2009) .
The aim of the present study was to determine whether there was a correlation between follicular fluid (FF) levels of AMH and aromatase mRNA expression in the corresponding GC of normal human follicles of a size at which AMH has been found to expressed in high concentrations. Furthermore, AMH and the AMH-receptor II mRNA expression was determined and correlated to the expression of FSH-receptor (FSH-r) and LH-receptor (LH-r) expression in the GC and to levels of estradiol, progesterone, androstendione, testosterone and inhibin-B in the corresponding FF samples.
Materials and Methods

Patients and collection of small antral FF
Granulosa cell and FF samples of individual small antral follicles were obtained by aspiration from ovaries surgically removed for fertility preservation. Isolation and cryopreservation of the ovarian cortex was offered to women with a disease where the appropriate treatment posed a high risk of subsequently making them sterile.
A total of 64 follicles were obtained from 24 women aged 15 -37 years (median 29 years) at a random time during their menstrual cycle. Diagnosis for ovarian cryopreservation included mammary cancer [9], Hodgkin's disease [3] , Ewing and other sarcoma [2], lymphoma [2] and various others [9] , which did not relate to an endocrinological (e.g. polycystic ovarian syndrome) and/or ovarian disease. All ovaries appeared normal by (i) visual inspection in connection with the cryopreservation procedure and (ii) by subsequent microscopical evaluation of histological sections from a small piece of the ovarian cortex.
The follicles were collected immediately after recovery of the ovary prior to isolation of the ovarian cortex. Each antral follicle visible on the surface of the ovary or observed during preparation of cortex was aspirated with a 1 ml syringe with a 26-gauge needle (Becton Dickinson, Brøndby, Denmark). The GC of each small follicle were isolated by centrifugation (2000g, 2 min). After isolating the FF, each ampoule of GC and FF were snap-frozen in liquid nitrogen and stored at 2808C until RNA purification or until measurement of hormones.
FF was collected from one to eight antral follicles per patient (1 FF 5 patients; 2 FF's 8 patients; 3 FF's 7 patients; 4 FF's 2 patients; 6 FF's 1 patients; 8 FF's 1 patient). The volume of the each follicle was estimated from the volume in the syringe and only those with a volume from 40 to 350 ml corresponding to 3 -9 mm in diameter were included in the study. The ethical committee of the municipalities of Copenhagen and Frederiksberg approved the project.
Pre-ovulatory FF from natural menstrual cycles
For comparison, pre-ovulatory FF from a total of 11 women suffering from tubal infertility (aged 34 + 1 years, range 28 -37) was included. They received infertility treatment with IVF following their natural menstrual cycle without administration of any exogenous gonadotrophins or medications. Ovulation induction was caused by the natural endogenous midcycle surge of gonadotrophins and was predicted by measuring the LH surge in the urine. One follicle was aspirated from each patient and fluid from this follicle included. All patients had normal menstrual cycles based on measurements of basal body temperature and progesterone concentrations.
RNA purification
Total RNA was purified under RNase-free conditions at room temperature using Tri Reagent (Sigma-Aldrich, St Louis, MO, USA) in combination with the RNAeasy Mini Kit (Qiagen, Hilden, Germany). Each cell sample was lysed in 1 ml Tri Reagent according to the Tri Reagent protocol and incubated at room temperature for 5 min. Following addition of 200 ml 1-bromo-3-chloro-propane (Sigma-Aldrich), the cell sample solutions were shaken vigorously for 15 s and incubated at room temperature for 5 min. Following centrifugation at 15 000g for 15 min at 48C the mixture separated into three phases and the upper aqueous phase containing the RNA was transferred to a clean, RNase-free Eppendorf tube. The following steps of RNA purification were carried out according to the RNeasy Mini Kit protocol. The final elution step was repeated and the purified total RNA was subsequently stored at 2608C.
The samples were analyzed for total RNA quality and level of degradation using an Agilent 2100 Bioanalyzer and RNA 6000 Pico LabChip according to the manufacturer's instructions (RNA 6000 Pico assay kit, Agilent Technologies, Waldbronn, Germany). RNA samples which did not show two relatively distinct peaks representing 18s and 28s rRNA were excluded. Quantity of the total RNA was evaluated using the Nanodrop w ND1000 Spectrophotometer (NanoDrop Technologies, Wilmington, DE, USA).
cDNA synthesis and RT -PCR analysis
First-strand cDNA was synthesized using the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Carlsbad, CA, USA) according to the manufactures manual. A master mix containing 2.0 ml 10Â RT Buffer, 0.8 ml 25Â dNTP Mix (100 mm), 2.0 ml 10Â RT Random Primers, 1.0 ml MultiScribe TM Reverse Transcriptase (50 U/ml), 1.0 ml RNase Inhibitor and 3.2 ml nuclease-free (DEPC) water was prepared and for each 20 ml reaction 10 ml master mix was added to an equal volume of total RNA (concentrations ranging from 5 to 10 ng/ml). All steps were performed on ice. Samples were centrifuged briefly at 12 000g and then incubated at room temperature for 10 min, followed by 378C for 2 h and finally, 858C for 5 s. First-strand cDNA was stored at 2208C until real-time PCR analysis.
Evaluation of gene expression levels was achieved by RQ (relative quantification) real-time PCR analysis using TaqMan w technology (Applied Biosystems). FSH-r, LH-r, Cyp19a1 and AMH-r2 TaqMan w Gene Expression Assays (pre-designed) as well as the Endogenous Control Assays for human b-actin and glyceraldehyde 3-phosphatdehydrogenase (GAPDH) were purchased from Applied Biosystems (Assay id-no.: b-actin:#4326315E; GAPDH:#4333764F; FSH-r:#Hs00174865_m1; LH-r: #Hs00174885_m1; AMH-r2:#Hs00179718_m1; CYP19(a1):#Hs009034 13_m1). Sample triplicates were prepared according to the manufacturer's instructions. A total reaction volume of 25 ml was prepared on ice containing 12.5 ml TaqMan w Universal PCR Master Mix, No AmpErase w UNG(2X), 1.25 ml 20X TaqMan w Gene Expression Assay Mix, 1.7-1.85 ml undiluted cDNA and RNase-free water up to 25 ml. The samples were then centrifuged at 2800g at 48C for 5 min.
cDNA was amplified using the 7500 Real-time PCR system (Applied Biosystems) under the following thermal cycling conditions: 958C for 10 min, 45 cycles of 958C for 15 s and 608C for 1 min. The data were subsequently analyzed using human b-actin and GAPDH as housekeeping genes and the SDS Software for Relative Quantification (Applied Biosystems).
Hormone measurements
Estradiol and progesterone were measured using commercially available RIA kits (DSL-43100 & DSL-3400; Diagnostic System Laboratories, Webster, TX, USA). Samples for both assays were diluted 1:50 in steroidfree serum just prior to measurement. Androstenedione was measured using RIA kit (DSL-3800, TX) with samples being diluted 1:200 in steroidfree serum and testosterone using RIA kit (DSL-4000, TX) diluted 1:100 in steroid-free serum.
AMH was measured using a specific ELISA-kit according to manufactures instructions (DSL-10-14400; Diagnostic System Laboratories). FF samples from small antral follicles were diluted either 1:500 or 1:3000 in the zero standard provided by the manufacturer. Inter-assay variation of a sample containing 7.6 ng AMH/ml was 4.4% (n ¼ 12) and intra-assay variation was 3.3% (n ¼ 5) of sample containing 0.45 ng/ml. Dilution curves of FF samples proved parallel to the standard curve.
Inhibin-B was measured using a specific ELISA-kit according manufactures instruction (The Oxford Bio-innovation kit; Biotech-IgG, Copenhagen, Denmark). Prior to measurement, all FF samples irrespective of whether they derived from small antral or pre-ovulatory follicles were diluted 1:100 or 1:500 in serum obtained from a pool of five post-menopausal women (who had no Inhibin-B activity). The FF were pre-treated with sodium dodecyl sulfate (SDS), heated and exposed to hydrogen peroxide before they were applied to the wells of the plate and incubated overnight at room temperature. Subsequently, the plates were washed and incubated with detection antibody for 3 h at room temperature. Substrate solution was applied and incubated for 1 h. The amplifier solution was added, and the plates were read with an ELISA reader at 490 nm with its reference at 620 nm (CV , 7%).
Statistics
For evaluation of a possible correlation between the levels of the measured substances Spearman correlation coefficient test was used. For comparison of levels of hormones measured in the pre-ovulatory FF and in FF from the antral follicles a Student's t-test was used. Least square linear regression analysis was also applied. P-value of ,0.05 was accepted as statistical significance.
Results
The aspirated volume in small antral follicles ranged from 30 to 350 ml (median 100 ml). Assuming that the follicle is spherical the corresponding follicular diameters spanned 3-9 mm. Concentrations of AMH in fluid from small antral follicles were two orders of magnitude higher than in pre-ovulatory FF obtained from women in their natural menstrual cycle having a normal endogenous mid-cycle surge of gonadotrophins (Table I ). In fluid from small antral follicles levels of AMH ranged from 42 to 2441 ng/ml. Levels of inhibin-B in fluid from small antral follicles were on average around seven times lower than that of AMH, but were still significantly higher than those observed in the preovulatory follicles (Table I ). Levels of steroids showed the expected pattern in both types of FF (Table I ).
The quality of the extracted total RNA allowed evaluation of the analyzed genes in 55 of the 64 samples. In the remaining nine samples the concentration of the extracted total RNA was too low or not of sufficient quality in order to quantify the gene expression levels.
Concentrations of AMH in small antral follicles showed a negative correlation with mRNA levels of CYP19 in the corresponding GC (P , 0.0007; Table II ). Figure 1 shows a plot of AMH versus the CYP19 expression showing the inverse correlation between the two parameters. However, despite the statistical significant correlation, it appears from the figure, that a small subpopulation of the follicles do not follow this correlation, where a relatively high AMH levels was recorded simultaneously with relatively high CYP19 expression. In this group of follicles, FF levels of estradiol remained very low and they followed a pattern similar to that of the remaining cohort of follicles.
Expression of AMH-r2 was unrelated to FF AMH levels using the Spearman correlation coefficient test and expression of FSH-r was not significant related to CYP19 and AMH expression (Table II) with AMH concentrations, although there appeared to be an inverse trend (P ¼ 0.055; Table II ).
In fluid from small antral follicles concentrations of AMH showed a strong negative correlation with estradiol, progesterone and inhibin-B (P , 0.004 for all), although FF levels of testosterone and androstenedione were unrelated (Table III) .
The results of the expression levels of AMH-r2 in relation to the other parameters measured in the follicles are presented by dividing AMH-r2 levels into four groups in order to make the groups of approximately similar size; the statistical tests were performed on the data set as a whole (Table IV) . The mRNA expression of AMH-r2 showed a large variation between individual follicles, with a relative difference between the maximum and minimum value of more than 400 times. However, there was a highly significant positive correlation to mRNA expression of the FSH-r (P , 0.0001, linear regression: P , 0.03), and to the expression of aromatase CYP19 (P ¼ 0.036), whereas mRNA expression of the other receptors and of hormones measured in the FF showed no significant correlations (Table IV) . From a plot of AMH-r2 and FSH-r expression it was not possible to identify a subgroup of follicles as observed in Fig. 1 (data  not shown) .
The aspirated volume of FF was, assuming that the follicle was spherical and that all FF was aspirated, used to calculate the follicular diameter. The number of follicles in each of following categories was: follicular diameter ,4 mm: 6; 4-5 mm: 11; 5-6 mm: 24; 6-7 mm: 11; 7-8 mm: 9; 8-9 mm: 3. The majority of follicles exhibited diameters between 4 and 7 mm and relating the measured parameters did not reveal significant correlations to the follicular diameter (Spearman correlation test).
As previously shown observations in individual follicles was not correlated to the individual from which it was collected but to the specific follicle (Yding and statistically each follicle was treated as one observation.
Discussion
The present study demonstrates that the intrafollicular concentrations of AMH in small human antral follicles are highly significantly inversely correlated to the mRNA expression of the aromatase enzyme (CYP19) that converts androgens to estrogens in the corresponding GC. Thereby this study confirms and expands earlier studies showing a strong negative correlation between the FF concentration of AMH and estradiol, a correlation, which indeed also was found in the present study. Thus results of the present study from normal small antral human follicles corroborate results from previous studies in which it was shown that AMH added to cultures of human granulosa-lutein cells obtained from IVF patients caused a significant reduction of the FSH stimulated estradiol secretion by reducing the expression of the aromatase enzyme (Grossman et al., 2008) and an inverse correlation between AMH and aromatase expression in bovine follicles (Monniaux et al., 2008; Rico et al., 2009 ). In addition, AMH added to the culture of fetal sheep ovaries showed a similar reduced effect on the aromatase expression and release of estradiol to the culture medium (Vigier et al., 1989) .
In contrast to AMH concentrations in FF, expression of the AMH-r2 on the GC showed a strong positive correlation to FSH-r expression and a significant correlation to aromatase expression. The negative correlation between the FF AMH levels (i.e. the ligand) and aromatase expression, and the positive correlation between AMH-r2 (i.e. the receptor) and aromatase and FSH-r expression makes it difficult to interpret the mechanistic pathways involved in the regulation of aromatase expression in the human immature GC. It may be that different factors and intracellular pathways regulate AMH and AMH-r2 and clearly a complicated interrelationship exists between these parameters. In order to study the more mechanistic relations in detail culture experiments are warranted in which GC from small human antral follicles are cultured with and without FSH and/or AMH stimulation to evaluate the effects of mRNA expression of FSH-r and AMH-r2. The health status of the follicles used in the present study was not assessed. Studies on normal human follicles of similar size to those of the present study showed, more than 25 years ago, that the majority was to some degree atretic (Westergaard et al., 1986) . The data presented in Fig. 1 appear to show in cohorts of follicles, a large group of follicles with relatively low levels of AMH in which there is a clear negative relationship between AMH and aromatase and then a small group of follicles in which high levels of AMH coexist with higher levels of aromatase. Further, based on immunohistochemical studies it has been suggested that healthy follicles have a stronger expression of AMH than atretic follicles (Visser et al., 2006) . Although this small group of follicles in the present study showed increased levels of aromatase in the presence of high levels of AMH, this was not reflected in FF estradiol levels, which remained very low. However, this small group of follicles exhibited increased levels of FSH-r mRNA expression (data not shown), and it may be speculated that these follicles represent the healthy follicles and the first large group of follicles to some extent have entered the atretic pathway. However, it is now well accepted that the group of follicles with diameters of around a few millimeters can be rescued and provide oocytes with a good pregnancy potential in connection with controlled ovarian stimulation and assisted reproduction. So the process of atresia is advanced only to a degree that allows salvation and we anticipate, that the present data reflects normal follicular development with good accuracy. However, in future studies, it will be of interest to assess the health status of the follicle simultaneously with recording the parameters as performed in the present study.
This study was unable to demonstrate significant correlations between the follicular diameter and the measured parameters. Although a correlation to follicular diameter could be expected for a number of substances (e.g. aromatase and LH-r expression) the majority of follicular diameters were found in a relatively narrow range of 4-7 mm and in addition the procedure by which the FF was aspirated may not have yielded the total volume of each individual FF in all cases. Furthermore, some variations in level of the measured hormones could be expected especially in relation to the health status of the follicle. However, in order to compensate for these shortcomings it is required to include a large number of follicles, possibly in combination with assessment of the follicular health status.
In a normal menstrual cycle, the granulosa cell synthesis of AMH becomes reduced when the follicle reaches a diameter of 8-10 mm coinciding with follicular selection and the development of significant differences in intrafollicular concentrations of estradiol between the selected and non-selected follicle ( 1996; Macklon and Fauser, 1998; Weenen et al., 2004) . Although the existence of a correlation between parameters as observed in the present study is not sufficient to propose a functional hypothesis, this study indicates that the major role of AMH is prior to selection of the dominant follicle and that AMH in these follicles in some way is engaged in maintaining low intrafollicular levels of estradiol when compared with that observed in pre-ovulatory follicles. In a physiological context, a low estradiol production in the follicular phase by the sub-ordinary follicles is required in order for them not to interfere with the important fine-tuned interplay between the pituitary and the dominant follicle that takes place in the last part of the follicular phase in order to facilitate ovulation of a fully mature oocyte. The ovaries are very dynamic organs where the pool of small antral follicles differs in size and composition with time and age of the woman. The concentration of AMH measured in circulation undergoes a well-known slow reduction with age and becomes almost undetectable close to the menopause reflecting that the pool of small follicles is reduced in a similar manner (van Disseldorp et al., 2008) . However, the estradiol production by the pre-ovulatory follicle seems only to a minor extent to be affected by age and does not seem to be affected by the pool of small antral follicles present in the ovaries. The intrafollicular concentration of AMH in small antral follicles has been shown to be independent of age (Yding and collectively this supports the notion that the main function of AMH is in the intrafollicular compartment as proposed by the present hypothesis.
The present study has, consistently with previous studies on small human antral follicles (Yding Andersen and Byskov, 2006; , shown that the intrafollicular concentrations of AMH show a highly significant inverse correlation with progesterone and inhibin-B concentrations. The present study suggests that AMH influences aromatase mRNA expression but it is difficult to reconcile how this mechanism should directly affect production of progesterone and inhibin-B, although a previous study also found AMH to affect progesterone secretion of GC in vitro (Kim et al., 1992) . Actually, follicular progesterone production is a follicular end product considered to be mainly under LH control and is the result of conversion of cholesterol to pregnenolone via the P450scc enzyme, which is then further converted into progesterone by the action of the 3b-hydroxy-steroiddehydrogenase enzyme (3-bHSD; Miller, 2008) . Inhibin-B production by the GC seems to be dependant on FSH stimulation (Welt and Schneyer, 2001 ). Studies in mice have shown that overexpressing AMH and increasing serum concentrations to almost 300 ng/ml leads to a significant reduced expression of Star, P450scc, 3-bHSD and P450 17a-hydroxylase/C17-20 lyase (P450c17; Racine et al., 1998) . So if AMH reduces the FSH induced aromatase expression it may be possible that it may also inhibit the FSH induced inhibin-B production and as in the mice affect expression of important steroidogenic enzymes. We now plan to study the mRNA expression of inhibin-B and genes involved in the progesterone synthesis pathway during culture experiments. Collectively these results suggest that AMH action affects other regulatory pathways than expression of the aromatase enzyme and may exert several intrafollicular functions.
For comparison the present study included FF from pre-ovulatory follicles obtained from women in their natural menstrual cycle collected shortly before ovulation following a normal mid-cycle surge of gonadotrophins. The concentrations of AMH in these follicles do confirmed a dramatic reduction going from the small antral to the preovulatory stage, but also show that the average AMH concentration in natural FF is somewhat higher than that reported for pre-ovulatory FF from women receiving pituitary down-regulation and ovarian stimulation (Yding Andersen and Byskov, 2006; Fanchin et al., 2007; Yding Andersen and Lossl, 2008) . The follicles of the present study were similar in size and volume to those normally found in women undergoing ovarian stimulation. The reduced levels of AMH may reflect that the collective number of immature GC in connection with ovarian stimulation is reduced when compared with the natural cycle, where increased levels of FSH accelerate follicular growth out of the stages at which AMH is expressed at high levels or the administration of exogenous FSH may cause the AMH reduction to occur more efficiently as have been suggested by studies in primates (Thomas et al., 2007) . However, other studies were unable to demonstrate an immediate effect of FSH on AMH down-regulation (Wachs et al., 2007) .
In conclusion, using fluid and GC from normal human follicles with a diameter of 3-9 mm, which is the stage with high AMH expression, it has been shown that the mRNA expression of the aromatase enzyme is highly significant inversely correlated to the intrafollicular concentration of AMH alongside a similar correlation between AMH and estradiol. On the other hand, mRNA expression of AMH-r2 exhibits a positive correlation to FSH-r and aromatase expression. These apparent opposing effects of the AMH/AMH-r2 on the immature human GC highlight the complex regulatory pathways which are involved in the AMH signaling and warrant further mechanistic studies to be performed.
